Dehydroaltenusin is a selective small-molecule inhibitor of eukaryotic DNA polymerase α (pol α), exhibiting antitumor activity against human adenocarcinoma in vivo; it arrests the cancer cell cycle at the S phase and induces apoptosis in human cancer cells.